Access options
Subscribe to Journal
Get full journal access for 1 year
$259.00
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Lupus in crisis: as failures pile up, clinicians call for new tools. Nat Biotechnol 37, 7–8 (2019). https://doi.org/10.1038/nbt0119-7
Published:
Issue Date:
Further reading
-
Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials
Modern Rheumatology (2021)
-
Treatment targets in SLE: remission and low disease activity state
Rheumatology (2020)
-
Anifrolumab in Systemic Lupus Erythematosus
New England Journal of Medicine (2020)
-
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
New England Journal of Medicine (2020)
-
Establishing Consensus Understanding of the Barriers to Drug Development in Lupus
Therapeutic Innovation & Regulatory Science (2020)